Novel Carbohydrate Ligands for a Serum Lectin Expressed on Colon Cancer Cells and Associated with Anti-tumor Activity
| Project/Area Number |
18590053
|
|---|
| Research Category |
Grant-in-Aid for Scientific Research (C)
|
| Allocation Type | Single-year Grants |
|---|
| Section | 一般 |
|---|
| Research Field |
Biological pharmacy
|
|---|
| Research Institution | Ritsumeikan University |
|---|
Principal Investigator |
KAWASAKI Nobuko Ritsumeikan University, Research Organization of Science & Engineering, Professor (70077676)
|
|---|
| Co-Investigator(Kenkyū-buntansha) |
KAWASAKI Toshisuke Ritsumeikan University, COE Research Organization, Professor (50025706)
MA Bruce Yong Ritsumeikan University, COE Research Organization, Associate Professor (00378788)
|
|---|
| Project Period (FY) |
2006 – 2007
|
| Project Status |
Completed (Fiscal Year 2007)
|
| Budget Amount *help |
¥3,920,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥420,000)
Fiscal Year 2007: ¥1,820,000 (Direct Cost: ¥1,400,000、Indirect Cost: ¥420,000)
Fiscal Year 2006: ¥2,100,000 (Direct Cost: ¥2,100,000)
|
|---|
| Keywords | Mannan-binding protein / Mannose-binding protein / Serum lectin / Human colorectal carcinoma cell / Carbohydrate ligands / CD26 / DPPIV / Lewis blood group antigen / 血清レクチン / 抗腫瘍活性 |
|---|
| Research Abstract |
The serum mannan-binding protein (MBP) is a host defense C-type lectin specific for mannose, N-acetylglucosamine and fucose residues, and has growth inhibitory activity to human colon cancer cells. In our previous study, the MBP-ligand oligosaccharides (MLO) isolated from a human colon cancer cell, SW1116, were characterized as large, multi-antennary N-glycans with highly fucosylated polylactosamine-type structures having Le^b-Le^a or tandem repeats of the Lea structure at their non-reducing ends. In this study, first we attempted to identify the glycoproteins, which carried the unique MLO.
1. We isolated the MBP-ligand glycoproteins (MLGPs) from the cell lysates by AAL and MBP-columns, and the two major MLGPs were identified as CD26 (Dipeptidylpeptidase IV (DPPPIV)) and CD98 heavy chain (CD98hc) by LC-MS/MS analysis.
2. The glycosidase digestions of these proteins indicated that the CD26 contained the complex-type N-glycans that bound MBP with high affinity, while CD98hc comprised only of high-mannose type N-glycans that did not bind MBP. Then, we purified CD26 from SW1116 cell lysates using an anti-human CD26 mAb affinity column.
3. The MALDI-MS analysis of the PNGase F released N-glycans from the purified CD26 demonstrated the presence of a series of tandem repeats of fucosylated N-acetyllactosamine (LacNAc). Thus CD26 was identified as a major MLO carrying protein.
4. By the comparison of the N-glycans released from the MBP-binding and-non-binding CD26 glycopeptides, the tandem repeat structure, longer than tetramer, of the Le^a epitope was shown to be critically important for the high affinity binding of the ligands to MBP.
5. The analysis of the N-glycan attachment sites of the CD26 glycopeptides demonstrated that the unique ligand was expressed preferentially at some potential N-glycosylation sites, but the preference was not so strict.
|
Report
(3 results)
Research Products
(32 results)
